Global Molecular Cytogenetics Market Size study, by Product (Kits & Reagents, Instruments, Consumables, Software & Services), by Application (Genetic Disorders, Cancer, Personalized Medicine, Other Applications), by End-use (Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Other End-users) and Regional Forecasts 2022-2028
- BIZ4953059
- 200 Pages
- April 2022
- Diagnostic and Biotech
The key regions considered for the Global Molecular Cytogenetics Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the rise in healthcare expenditure. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as high incidence and large economic burden of genetic disorders and cancer, presence of pharmaceutical and biotechnology companies are responsible for lucrative growth prospects for the Molecular Cytogenetics Market across Asia Pacific region.
Major market players included in this report are:
Thermo Fisher Scientific Inc
ABBott Laboratories, Inc.
Agilent Technologies, Inc.
Applied Spectral Imaging
Bio-Rad Laboratories, Inc.
Danaher Corporation
Illumina, Inc.
Oxford Gene Technology (OGT)
PerkinElmer, Inc.
Hoffmann-LA Roche Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Kits & Reagents
Instruments
Consumables
Software & Services
By Application:
Genetic Disorders
Cancer
Personalized Medicine
Other Applications
By End-Use:
Clinical & Research Laboratories
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Other End-users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Molecular Cytogenetics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Molecular Cytogenetics Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Molecular Cytogenetics Market, by Product, 2020-2028 (USD Billion)
1.2.3. Global Molecular Cytogenetics Market, by Application, 2020-2028 (USD Billion)
1.2.4. Global Molecular Cytogenetics Market, by End-use, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Molecular Cytogenetics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Molecular Cytogenetics Market Dynamics
3.1. Molecular Cytogenetics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing Incidence of Genetic Disorders and Cancer
3.1.1.2. Exponential rise in population and chronic diseases
3.1.2. Market Challenges
3.1.2.1. High Costs
3.1.3. Market Opportunities
3.1.3.1. Technological advancements
Chapter 4. Global Molecular Cytogenetics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Molecular Cytogenetics Market, by Product
6.1. Market Snapshot
6.2. Global Molecular Cytogenetics Market by Product, Performance - Potential Analysis
6.3. Global Molecular Cytogenetics Market Estimates & Forecasts by Product, 2019-2028 (USD Billion)
6.4. Molecular Cytogenetics Market, Sub Segment Analysis
6.4.1. Kits & Reagents
6.4.2. Instruments
6.4.3. Consumables
6.4.4. Software & Services
Chapter 7. Global Molecular Cytogenetics Market, by Application
7.1. Market Snapshot
7.2. Global Molecular Cytogenetics Market by Application, Performance - Potential Analysis
7.3. Global Molecular Cytogenetics Market Estimates & Forecasts by Application, 2019-2028 (USD Billion)
7.4. Molecular Cytogenetics Market, Sub Segment Analysis
7.4.1. Genetic Disorders
7.4.2. Cancer
7.4.3. Personalized Medicine
7.4.4. Other Applications
Chapter 8. Global Molecular Cytogenetics Market, by End-use
8.1. Market Snapshot
8.2. Global Molecular Cytogenetics Market by End-use, Performance - Potential Analysis
8.3. Global Molecular Cytogenetics Market Estimates & Forecasts by End-use 2019-2028 (USD Billion)
8.4. Molecular Cytogenetics Market, Sub Segment Analysis
8.4.1. Clinical & Research Laboratories
8.4.2. Academic Research Institutes
8.4.3. Pharmaceutical and Biotechnology Companies
8.4.4. Other End Users
Chapter 9. Global Molecular Cytogenetics Market, Regional Analysis
9.1. Molecular Cytogenetics Market, Regional Market Snapshot
9.2. North America Molecular Cytogenetics Market
9.2.1. U.S. Molecular Cytogenetics Market
9.2.1.1. Product breakdown estimates & forecasts, 2019-2028
9.2.1.2. Application breakdown estimates & forecasts, 2019-2028
9.2.1.3. End-use breakdown estimates & forecasts, 2019-2028
9.2.2. Canada Molecular Cytogenetics Market
9.3. Europe Molecular Cytogenetics Market Snapshot
9.3.1. U.K. Molecular Cytogenetics Market
9.3.2. Germany Molecular Cytogenetics Market
9.3.3. France Molecular Cytogenetics Market
9.3.4. Spain Molecular Cytogenetics Market
9.3.5. Italy Molecular Cytogenetics Market
9.3.6. Rest of Europe Molecular Cytogenetics Market
9.4. Asia-Pacific Molecular Cytogenetics Market Snapshot
9.4.1. China Molecular Cytogenetics Market
9.4.2. India Molecular Cytogenetics Market
9.4.3. Japan Molecular Cytogenetics Market
9.4.4. Australia Molecular Cytogenetics Market
9.4.5. South Korea Molecular Cytogenetics Market
9.4.6. Rest of Asia Pacific Molecular Cytogenetics Market
9.5. Latin America Molecular Cytogenetics Market Snapshot
9.5.1. Brazil Molecular Cytogenetics Market
9.5.2. Mexico Molecular Cytogenetics Market
9.6. Rest of The World Molecular Cytogenetics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. ABBott Laboratories, Inc.
10.2.3. Agilent Technologies, Inc.
10.2.4. Applied Spectral Imaging
10.2.5. Bio-Rad Laboratories, Inc.
10.2.6. Danaher Corporation
10.2.7. Illumina, Inc.
10.2.8. Oxford Gene Technology (OGT)
10.2.9. PerkinElmer, Inc.
10.2.10. Hoffmann-LA Roche Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
TABLE 1. Global Molecular Cytogenetics Market, report scope
TABLE 2. Global Molecular Cytogenetics Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Molecular Cytogenetics Market estimates & forecasts by Product 2019-2028 (USD Billion)
TABLE 4. Global Molecular Cytogenetics Market estimates & forecasts by Application 2019-2028 (USD Billion)
TABLE 5. Global Molecular Cytogenetics Market estimates & forecasts by End-Use 2019-2028 (USD Billion)
TABLE 6. Global Molecular Cytogenetics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Molecular Cytogenetics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Molecular Cytogenetics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Molecular Cytogenetics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Molecular Cytogenetics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Molecular Cytogenetics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Molecular Cytogenetics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Molecular Cytogenetics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Molecular Cytogenetics Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Molecular Cytogenetics Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. U.S. Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. Canada Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 20. Canada Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. Canada Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. UK Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 23. UK Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. UK Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. Germany Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 26. Germany Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. Germany Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. RoE Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 29. RoE Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. RoE Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. China Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 32. China Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. China Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. India Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 35. India Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. India Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. Japan Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 38. Japan Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. Japan Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. RoAPAC Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 41. RoAPAC Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. RoAPAC Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. Brazil Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 44. Brazil Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Brazil Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Mexico Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 47. Mexico Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. Mexico Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. RoLA Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 50. RoLA Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. RoLA Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. Row Molecular Cytogenetics Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 53. Row Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. Row Molecular Cytogenetics Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of Global Molecular Cytogenetics Market
TABLE 56. List of primary sources, used in the study of Global Molecular Cytogenetics Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
